ICU环境分离肺炎克雷伯菌分子分型及耐药性分析

doi:10.19485/j.cnki.issn2096-5087.2020.04.016

Preventive Medicine

2020, Vol. 32

Issue (4): 388-391 DOI: 10.19485/j.cnki.issn2096-5087.2020.04.016

Current Issue | Archive | Adv Search

Abstract
Figure/Table
References
Related Citation (15)

[1] 朱静,周义正,罗金柱,等.2015—2017年荆州市中心医院临床分离菌分布及耐药性分析[J/OL].中国抗生素杂志,2019(10):1189-1197[2019-12-18].https://doi.org/10.13461/j.cnki.cja.006727.
[2] 许立,郭英华,刘长庭.肺炎克雷伯菌对临床常见抗生素耐药机制研究进展[J].解放军医学院学报,2019,40(2):186-189.
[3] 胡付品,郭燕,朱德妹,等.2017年CHINET中国细菌耐药性监测[J].中国感染与化疗杂志,2018,18(3):241-251.
[4] AYATOLLAHI A A,AMINI A,RAHIMI S,et al.Prevalence of gram-negative bacilli isolated from the equipment and surfaces in hospital wards of Golestan province,North of Iran[J].Eur J Microbiol Immunol(Bp),2017,7(4):261-266.
[5] 中华人民共和国卫生部.医院消毒卫生标准:GB 15982—2012[S].北京:中国标准出版社,2012.
[6] 中华人民共和国卫生部医政司.全国临床检验操作规程[M].3版.南京:东南大学出版社,2006.
[7] RIBOT E M,FAIR M A,GAUTOM R,et al.Standardization of pulsed field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7,Samonella,and Shigella for PulseNet[J].Foodborne Pathog Dis,2006,3(1):59-67.
[8] TENOVER F C,ARBEIT R D,GOERING R V,et al.Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis:criteria for bacterial strain typing[J].J Clin Microbiol,1995,33(9):2233-2239.
[9] Clinical and Laboratory Standards Institute.Performance standards for antimicrobial susceptibility testing.28th ed.CLSI supplement M100[S].Wayne,PA:Clinical and Laboratory Standards Institute,2018.
[10] 宋婧源,许亚茹,元小冬,等.NICU肺炎克雷伯菌医院感染的病房环境传播特征研究[J].中华医院感染学杂志,2018,28(19):2885-2888,2897.
[11] 王会平,张洪江,董歧,等.朝阳区医院环境中病原菌种类分布调查[J].中国消毒学杂志,2014,31(12):1298-1300.
[12] MURPHY C N,CLEGG S.Klebsiella pneumoniae and type 3 fimbriae:nosocomial infection,regulation and biofilm formation[J].Future Microbiol,2012,7(8):991-1002.
[13] 仇广翠,孙明忠,邵良荣,等.肺炎克雷伯菌在医院环境中的分布及耐药性分析[J].检验医学,2015,30(2):160-162,166.
[14] 苏乐斌,李柏生,谭海芳,等.广东省肇庆市肺炎克雷伯菌临床分离株的耐药性与MLST分型研究[J].中国抗生素杂志,2019,44(2):260-265.
[15] SUAY-GARC A B,PéREZ-GRACIA M T.Present and future of Carbapenem-resistant Enterobacteriaceae(CRE)infections[J].Antibiotics(Basel),2019,8(3):e122.